Background: Long-term care facilities (LTCFs) are thought to be important reservoirs of antimicrobial-resistant (AMR) bacteria; however, there is no routine surveillance of resistance in LTCF residents, or large populationbased studies comparing AMR in LTCFs with the community, so the relative burden of AMR in LTCFs remains unknown.
Introduction
The spread of antimicrobial resistance (AMR) is a major healthcare concern.
1 Owing to the paucity of new antibiotics being developed, a rise in AMR limits treatment options and increases the risk of treatment failure, leading to increases in morbidity and mortality. 2 Of particular concern are recent increases in hospital infections due to strains of Gram-negative bacteria such as Klebsiella and Escherichia coli that are resistant to all first-line antibiotics. 1, 3 Gram-negative bacteria are now the most common cause of hospital-acquired infection in England, Wales and Northern Ireland, causing 50 000 (63%) bloodstream infections (BSIs) in adults in 2011-12.
1 They were also the most common cause of BSIs in Scotland in 2012. 4 E. coli and Klebsiella are organisms of particular concern and have been highlighted as bacteria to monitor for resistance in the 5 year AMR strategy for the UK (2013-18). and Klebsiella pneumoniae BSIs in England have increased by 20.8% from 2009 to 2014. BSIs caused by other species have remained constant or declined. 6 Elderly individuals, particularly long-term care facility (LTCF) residents, are at increased risk of infection-related hospital admissions. 7 Infections and colonization in patients 65 years old are more likely to be caused by AMR bacteria, although this varies for different pathogen-antibiotic combinations. [8] [9] [10] [11] Urinary tract infections (UTIs), caused primarily by Gram-negative bacteria such as E. coli, Proteus and Klebsiella, are the second most frequent type of infection for elderly women. 12, 13 In England, UTIs were found to be the second most common healthcare-associated infection after respiratory tract infections, both in the hospital setting (17.2%) and the LTCF setting (35.7%). 14, 15 UTIs were the joint most common healthcareassociated infection with respiratory tract infections (31%), in a point-prevalence survey carried out in LTCFs across Europe. 15 It is estimated that in England, 4% of those aged .65 years (325 000 people) live in LTCFs. 7 Like hospitals, LTCFs are enclosed environments with high concentrations of frail elderly residents who are more likely to require daily living assistance, antibiotic treatment and invasive devices such as catheters. 16 At any one time in Europe between 4.8% and 15.2% of LTCF residents are being treated with antibiotics and between 47% and 79% of LTCF residents in Canada, the USA and Italy receive at least one course of antibiotics per year. 17 In Hampshire (England) , residence in an LTCF has recently been shown to be associated with high antibiotic consumption. 18 Control of infections can be challenging in LTCFs due to frequent opportunities for transmission through group activities, sharing of living space, objects and bathroom facilities, and lack of infection control provision. 16 AMR is not routinely surveyed in LTCFs, such that the extent of the problem is hidden and there is a lack of co-ordinated action to address the issue. We aimed to compare the frequency of antibiotic resistance of urinary tract bacteria from residents of LTCFs for the elderly and adults aged 70 years or older living in the community. To our knowledge, there are no large population-based studies, which include samples from both general practitioners (GPs) and hospitals that have addressed this question.
Methods
Ethics PHE has National Information Governance Board for Health and Social Care approval for the collation and analysis of this surveillance data in accordance with section 251 of the NHS Act 2006. This study was a secondary analysis of routinely collected AmSurv data.
Data sources
Three sources of data were used in this study. First, the antibiotic susceptibility results from all E. coli or Klebsiella culture-positive urine specimens collected from individuals aged 70 years or older reported from the 15 microbiology laboratories in the West Midlands to AmSurv (an AMR surveillance tool 19 ) from 1 April 2010 to 31 March 2014. The West Midlands Region (England) comprises a population of 700 000 aged 70 years or older. 20 Following national guidelines, we assumed that all urine samples were submitted due to clinical need and therefore were indicative of a suspected UTI. 21 The dataset did not contain sufficient clinical information to identify urine samples from catheters or distinguish between UTIs and asymptomatic bacteriuria, common in the elderly population in particular among those residing in LTCFs. 22 Samples from all types of suspected UTIs were considered. All West Midland laboratories undertake UKAS external accreditation to verify competencies and assure of conformity to standard methods. 23 Laboratory information systems are configured to only send significant bacteriuria to PHE and PHE recommends specific cut-offs for clinical laboratory processing. 24 Resistant bacteria were either fully resistant or intermediately resistant to a particular antibiotic. Clinical laboratories in England perform antibiotic susceptibility testing using a variety of methods: EUCAST, BSAC and CLSI (formerly NCCLS); with a mixture of automated (e.g. Vitek and Phoenix) and manual (e.g. disc and Etest) laboratory methods. All laboratories who contribute to this dataset participate in the UK National External Quality Assurance Scheme (NEQAS). Clinical laboratories most commonly use EUCAST breakpoints, and until recently BSAC methodology, but where EUCAST breakpoints are unavailable for key antibiotics, laboratories use alternative published breakpoints such as those of CLSI, and are asked to report their methods to NEQAS when reporting specific organism antibiotic susceptibility results. Specifically in the West Midlands, in 2012, of 15 laboratories, 7 laboratories used BSAC disc diffusion, 4 used Vitek 2, 3 used breakpoint methods and 1 used a combination of Vitek 2 and BSAC disc diffusion (depending on if tests were performed during normal working hours) to test antibiotic susceptibility. 25 The breakpoint method involves seeding agar plates with a concentration of antibiotic equivalent to the breakpoint for each antibiotic. 26 Diluted organisms are spotted on the antibiotic plates and on control plates containing no antibiotics. Seven of the eight laboratories using the BSAC method reported using the latest breakpoints during the study period. The remaining laboratory used an earlier version (version 10). Vitek 2 software uses EUCAST v1.1 (2010) breakpoints. During the study, two laboratories switched from using the BSAC method to a breakpoint technique.
The CLSI breakpoints for ceftazidime [one of the four third-generation cephalosporins (3GCs) tested] changed in 2010 and this change was implemented in automated systems between 2012 and 2013. In 2012, no laboratories in the West Midlands reported using CLSI breakpoints for this antibiotic. However, the methods used may have changed from 2012 to 2014, which is a limitation of the percentage of 3GCs reported. However, in our dataset, ceftazidime resistance constituted a fraction of what we report as 3GC resistance (33% of 3GC tests for Klebsiella and 19% for E. coli) and there was no stepwise increase or decrease in the percentage of urinary E. coli and Klebsiella resistant to ceftazidime in any of the West Midlands laboratories. In addition, across all non-specialist microbiology laboratories in the region, 50% of urine samples come from the community with LTCFs sending samples to their closest laboratory rather than having a specific managed contract with one laboratory within the region.
Data cleaning and de-duplication is described in Appendix S1 and Figure S1 (available as Supplementary data at JAC Online).
LTCF status (nursing or residential), bed numbers for the entire LTCF and LTCF postcodes (LTCF-pc) were extracted from the publicly available registry of LTCFs by the national regulator of health and social care in England (the Care Quality Commission). 27 LTCFs in the national register were included if they were classified as 'care homes' for elderly residents and recorded as active in the register from 2011 to 2012 (797 LTCFs). Care homes, as defined by the Care Quality Commission, 'offer accommodation and personal care for people who may not be able to live independently'. 28 We subsequently refer to care homes with 24 h medical care from qualified nursing staff as nursing LTCFs and to care homes without this service as residential LTCFs.
Postcodes containing only communal establishments (CE-pc) in the West Midlands and age-stratified population estimates for mid-2014 were taken from open data held by the Office for National Statistics. 20, 29 Data linkage 
Crude rate comparisons
Positive urinary tract bacterial cultures with E. coli and Klebsiella reported to AmSurv were used as a surrogate for E. coli and Klebsiella UTI, as urinary tract specimens should only be sent to the microbiology laboratory when there is a clinical suspicion of a UTI. 21 E. coli and Klebsiella samples were grouped as these were the most common Gram-negative bacteria with similar antibiotic treatment. Proteus isolates were not included as these bacteria are intrinsically resistant to nitrofurantoin. 30 The rates of E. coli and Klebsiella UTI and E. coli and Klebsiella UTI caused by resistant bacteria in LTCF-pc and in non-LTCF-pc are calculated as per Appendix S2. Postcodes may cover several buildings; therefore, LTCF-pc may also include some elderly people who are not LTCF residents. Sensitivity analysis estimated the rates of E. coli and Klebsiella UTI in LTCFs using only data from LTCF-pc that were classified by the Office for National Statistics as LTCF CE-pc.
Comparison of resistance levels in culture-confirmed samples
Logistic regression models coded in the rms package in R were used to calculate the odds of resistance for bacteria in LTCF samples compared with non-LTCF samples. 31 Further analyses compared nursing and residential LTCFs. Age group (70-74, 75-80, 81-85 and .85 years), sex, year of study (2010-11, 2011-12, 2012-13 and 2013-14) and sender (GP versus hospital) were included in the model as categorical covariates because they are known risk factors of antibiotic resistance for urinary tract bacteria (see Appendix S3). No interactions between the model variables improved model fit; therefore, they were not included in the final model (see Table S1 ).
Results
A total of 144 738 individuals aged 70 years or older had at least one positive urine specimen reported to the AmSurv database from any of the 15 diagnostic microbiology laboratories in the West Midlands region. The most commonly reported bacterium in the dataset was E. coli (57.2%). Klebsiella spp. accounted for 6.2% of the samples (of which 65% were K. pneumoniae, 19% were Klebsiella oxytoca and 15% were other Klebsiella of undefined species). Table 1 describes the key characteristics of E. coli and Klebsiella in LTCF samples and non-LTCF samples. LTCF samples were more frequently reported from the very elderly age groups (.85) than non-LTCF samples. LTCF samples (and non-LTCF samples) comprised samples sent by both GPs and hospitals (e.g. during an LTCF resident's hospital stay). LTCF samples were more frequently sent by GPs (versus hospitals) than non-LTCF samples. Overall, most samples were taken from females. This difference in gender was greater for LTCF samples than for non-LTCF samples.
The rate of laboratory-confirmed E. coli and Klebsiella UTI was 20.6 per 100 person years in LTCF residents and 7.8 per 100 person years in community dwelling older adults; giving a rate ratio (RR) of 2.66 (95% CI " 2.58-2.73) (see Table 2 ). In the sensitivity analysis, the rate of E. coli and Klebsiella UTI in the LTCFs located in CE-pc was similar (21.5 per 100 person years) giving a similar RR of 2.77 (95% CI " 2.57-2.98) (see Table S2 ).
The rate of E. coli and Klebsiella UTI caused by bacteria resistant to trimethoprim per 100 person years was 12.7 in LTCF residents versus 2.9 in community residents (RR " 4.41, 95% CI " 4.25-4.57) (see Table 2 ). The rate of E. coli and Klebsiella UTI caused by bacteria resistant to nitrofurantoin per 100 person years was 1.7 in LTCF residents versus 0.4 in community residents (RR " 4.38, 95% CI " 3.98-4.83). The rate of E. coli and Klebsiella UTI caused by Table S2 ). The prevalence of antibiotic resistance was higher in bacteria from LTCF samples than in non-LTCF samples for all bacteriumantibiotic combinations (Tables 3 and 4 ). E. coli resistance to: trimethoprim was 60% versus 37% [adjusted OR " 2.36, 95% CI " 2.21-2.53]; nitrofurantoin was 7% versus 4% (adjusted OR " 1.74, 95% CI " 1.53-1.97); ciprofloxacin was 29% versus 14% (adjusted OR " 2.42, 95% CI " 2.17-2.69); and 3GCs was 10% versus 6% (adjusted OR " 1.89, 95% CI " 1.64-2.17). Klebsiella resistance to: trimethoprim was 41% versus 26% (adjusted OR " 1.89, 95% CI " 1.6-2.24); nitrofurantoin was 41% versus 34% (adjusted OR " 1.31, 95% CI " 1.09-1.59); ciprofloxacin was 10% versus 8% (adjusted OR " 1.54, 95% CI " 1.13-2.1); and 3GCs was 8% versus 7% (adjusted OR " 1.24, 95% CI " 0.85-1.83). Further results of the univariate and multivariate results are shown in Tables S3-S9 and  Appendix S4. LTCFs with nursing support had higher levels of resistance to most antibiotics than residential LTCFs (see Table 3 and Table S10 ). Levels of antibiotic resistance were also higher in urinary tract bacteria from LTCF residents (obtained both from GPs and hospitals) than from hospitals (including samples from residents of LTCF-pc and non-LTCF-pc) (Table S11 ). E. coli resistance to trimethoprim, nitrofurantoin, ciprofloxacin and 3GCs was higher in LTCF samples than in hospital samples (60% versus 40%, 7% versus 4%, 29% versus 16% and 11% versus 8%). Klebsiella resistance to trimethoprim and nitrofurantoin was also higher in LTCFs (41% versus 27% and 41 % versus 32%) but ciprofloxacin resistance was similar (10% versus 10%) and 3GC resistance was higher in hospitals (8% versus 10%).
There were differences in resistance to trimethoprim, nitrofurantoin, ciprofloxacin and 3GCs over the study period for bacteria from LTCF samples and non-LTCF samples. These patterns are plotted in Figure 1 . Resistance to other antibiotics is plotted in Figures S2 and S3 . Table S2 for the sensitivity analysis calculating LTCF rates only for LTCFs in CE-pc. Urinary tract E. coli and Klebsiella reported to AmSurv. c 3GCs include ceftazidime, cefpodoxime, cefotaxime and ceftriaxone. Antimicrobial resistance in long-term care facilities and the community
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Discussion
Elderly residents of LTCFs are more than twice as likely as community dwelling adults of similar age to present with a laboratoryconfirmed E. coli or Klebsiella UTI. These infections are most commonly caused by E. coli. In LTCF residents 60% of samples that yielded E. coli were resistant to trimethoprim, 29% to ciprofloxacin, 10% to 3GCs and 7% to nitrofurantoin; 41% of samples that grew Klebsiella were resistant to trimethoprim, 41% to nitrofurantoin, 10% to ciprofloxacin and 8% to 3GCs. LTCF residents were over four times more likely than community dwelling older people to develop a laboratory-confirmed E. coli or Klebsiella UTI caused by resistant bacteria. The increased risk of antibiotic resistance among bacteria causing culture-confirmed E. coli and Klebsiella UTIs in the elderly residing in LTCFs is seen across antibiotic classes. Since 2012, all laboratories in the West Midlands report to AmSurv, making data from this region the most complete source of AMR data and providing insight into the burden and temporal changes of AMR within a defined population. Matching patient postcodes to LTCF-pc registered by the national regulator of health and social care in England unearths unprecedented knowledge of AMR in this setting over 4 years. The AmSurv surveillance system collects routine diagnostic samples from both community and hospital settings, permitting a fuller understanding of AMR in the population than other surveillance systems. In the multivariable analyses, statistically significant differences between the odds of antibiotic resistance in LTCF and non-LTCF settings are adjusted for clustering at the postcode level and account for variation in antibiotic resistance due to key risk factors (e.g. samples being sent from hospitals). Differences between residential and nursing LTCFs were also explored.
There were a number of limitations associated with using a large surveillance dataset. The dataset did not contain sufficient clinical information to identify urine samples from catheters or distinguish between UTIs and asymptomatic bacteriuria, common in the elderly population in particular among those residing in LTCFs. 22 However, clinical guidelines emphasize that only urinary samples from patients with a clinically suspected UTI and either a risk factor for resistance or a history of UTIs should be sent for laboratory testing and that catheter samples should not be sent. 21, 32 This dataset only included positive samples. The likelihood of an elderly individual with a UTI having a urinary sample submitted might differ in LTCF residents and those living in the community, which could bias results. Separately, there is evidence for variation in the rate of submission of community samples from GPs to laboratories. 33 This is an unquantified potential confounder; however, this variation should be less pronounced in older populations, as English national guidance advocates sampling all patients .65 years old with two or more signs of UTI. 34 Sampling may be biased towards those failing to respond to treatment, which could increase the apparent risk of resistance. However, it is unclear why this bias would be greater in LTCF samples than in samples from the community. Urinary tract samples reported to AmSurv with confirmed culture results for E. coli and Klebsiella accounted for 63% of urinary tract bacteria samples. Caution must therefore be applied before extrapolating our results to UTIs caused by other bacterial species. Another limitation is that the threshold to diagnose UTI might be lower in LTCFs as staff might notice UTI symptoms earlier than would otherwise be detected in individuals living in their own homes. In addition, cognitive impairment was not recorded. Therefore, the analysis could not take into account differences in this condition in the two populations, which may lower the diagnosis threshold due to the inability of patients to verbalize symptoms. The study also is limited by the in vitro measurement of resistance, which does not always equate to clinical failure. It should also be noted that different breakpoints for ceftazidime (one of the four 3GCs tested) may have been used during the time period. However, the majority of laboratories were using BSAC/ EUCAST breakpoint standards and this change was not apparent in our data (see the Methods section for details). Finally, as LTCF residence is not routinely recorded, we needed to infer this from patient postcodes. Thus, while those living in non-LTCF-pc are highly unlikely to be LTCF residents, a proportion of those living in LTCF-pc will live in the community in neighbouring households. This will Table S1 ). c 3GCs include ceftazidime, cefpodoxime, cefotaxime and ceftriaxone.
Rosello et al . 70  65  60  55  50  45  40  35  30  25  20  15  10  5  0  70  65  60  55  50  45  40  35  30  25  20  15  10  5  0  70  65  60  55  50  45  40  35  30  25  20  15  10  5  0  70  65  60  55  50  45  40  35  30  25  20  15 Antimicrobial resistance in long-term care facilities and the community JAC tend to bias ORs toward the null hypothesis, potentially leading to underestimates of the impact of LTCF residence on antibiotic resistance. LTCF UTI rates were similar when using the more specific postcodes that contained only communal establishments, suggesting that this bias was minimal. This methodology has previously been employed in other studies. 7, 18 Trimethoprim and nitrofurantoin are recommended as first-line treatments for UTI; 21 therefore, resistance to these agents can result in treatment failure, hospitalization and the subsequent use of antibiotics such as ciprofloxacin or 3GCs that should be reserved for the treatment of more serious infections. Our findings suggest that a large proportion of E. coli and Klebsiella UTIs in the elderly will not respond to trimethoprim treatment and that this problem is heightened in LTCFs, where the prevalence of resistance is even higher; 39% of UTIs caused by E. coli and 27% of UTIs caused by Klebsiella (60% and 41%, respectively, in LTCFs) were resistant to trimethoprim, which is the most commonly prescribed antibiotic of those recommended in empirical guidelines for lower UTI (54.2%). 35 One explanation for these high levels of resistance could be the high consumption of this antibiotic in England (6.4% of all antibiotics consumed in the community and 3.9% in hospitals in 2013). 35 Resistance to trimethoprim increased during the study period, faster for LTCF samples (E. coli from 53% to 63% and Klebsiella from 34% to 43%) than for non-LTCF samples (E. coli from 35% to 38% and Klebsiella from 22% to 29%). These increases could partly be explained by trimethoprim consumption increasing in England by 4.2% between 2010 and 2013. 35 The prevalence of resistance of E. coli and Klebsiella to nitrofurantoin was high for Klebsiella (35%) but much lower for E. coli (4%). This suggests nitrofurantoin might still be very effective in treating UTIs caused by E. coli in the elderly, particularly in women, where the adjusted OR of acquiring a UTI caused by nitrofurantoin-resistant E. coli is lower. Nitrofurantoin comprised 3.8% of all antibiotics consumed in England in 2013 in the community and was the second most frequently prescribed antibiotic agent of those recommended in empirical guidelines for lower UTI (20.8%). 36 In the West Midlands, the consumption of nitrofurantoin increased by 66% from 2010 to 2014. 6 Ciprofloxacin, 3GCs and carbapenems are antibiotics that are almost exclusively administered in hospitals for the treatment of severe infections. Ciprofloxacin treatment is recommended only in UTIs with acute prostatitis or acute pyelonephritis and 3GCs are not recommended in the empirical treatment of UTIs but are needed to treat more severe infections such as bacterial meningitis. 21, 35 Given this, the prevalence of resistance to ciprofloxacin in E. coli (15%) is concerning, in particular in LTCF samples (29%). The levels of resistance to ciprofloxacin in Klebsiella and to 3GCs in E. coli and Klebsiella were lower (8%, 6% and 7%, respectively). Although low, Klebsiella resistance to ciprofloxacin and 3GCs increased steadily during the study period for LTCF samples (from 6% to 14% for ciprofloxacin and 3% to 12% for 3GCs) and also increased, although slower, in non-LTCF samples (7% to 10% for ciprofloxacin and from 6% to 9% for 3GCs). E. coli resistance to ciprofloxacin and 3GCs remained stable. During the study period, quinolone consumption in the West Midlands remained fairly stable but the consumption of 3GCs increased by 21%. 6 Importantly, 3GC and ciprofloxacin resistances do not only result in treatment failures but in the prescription of 'last resort' antibiotics such as carbapenems. 1 In our study, the prevalence of resistance in urinary tract bacteria to carbapenems in the over 70s was similarly low in both Klebsiella and E. coli (0.2% and 0.02%, respectively) compared with what has been reported in the literature between 2010 and 2013 in the overall West Midlands population, 25 which prevented any formal statistical analysis but is reassuring. This is the first large population study to compare formally the AMR in LTCF residents with that in the elderly living in the community combining hospital and GP surveillance data. It is also the first large-scale study to quantify the burden of AMR in English LTCFs, where resistance levels and the LTCFs themselves could be different to LTCFs in other countries. Other studies were too small to yield statistically robust conclusions for several resistances, did not include GP samples or did not carry out a formal statistical comparison. [36] [37] [38] [39] [40] [41] Our findings highlight the very high levels of AMR bacteria in LTCF residents compared with their community counterparts and even to hospital patients, showing the importance of reducing antibiotic usage in LTCFs through antibiotic stewardship programmes and the need for LTCF-specific surveillance that can guide empirical treatment. We found that that a very high proportion of E. coli and Klebsiella UTIs in the elderly living in LTCFs (and a high proportion of those living in their own homes) will not respond to trimethoprim treatment. However, resistance to nitrofurantoin remains low in UTIs caused by E. coli but high in UTIs caused by Klebsiella, demonstrating the need to understand further the mechanisms for the selection of resistance. To understand why there are such high levels of resistance in LTCFs, more information about antibiotic prescription, recent hospitalizations and transmission of resistant bacteria is required. It is equally important that interventions are developed to reduce the risk of transmission of AMR bacteria in LTCF residents.
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